Summary

Persistence Market Research has recently published a detailed report on the global Cardiac Surgery Devices Market, offering comprehensive insights into the market’s dynamics, including growth drivers, emerging trends, opportunities, and key challenges. The report equips stakeholders with vital information to support strategic planning and investment decisions.

Key Insights:

• Cardiac Surgery Devices Market Size (2025E): US$ 2.0 Bn
• Projected Market Value (2032F): US$ 2.6 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 3.9%

Cardiac Surgery Devices Market - Report Scope:

The cardiac surgery devices market comprises a diverse array of tools and systems used in the diagnosis, treatment, and surgical management of heart-related conditions. These include cardiopulmonary bypass systems, artificial heart valves, ventricular assist devices, and implantable rhythm management tools. The increasing prevalence of cardiovascular diseases, combined with advancements in surgical techniques and device innovation, is reshaping the global landscape of cardiac care. As minimally invasive procedures and robotic-assisted surgeries gain traction, there is a growing demand for precise, efficient, and patient-friendly cardiac surgical equipment.

Market Growth Drivers:

The growth of the global cardiac surgery devices market is primarily driven by the rising incidence of cardiovascular diseases across the world. Sedentary lifestyles, poor dietary habits, and aging populations are contributing to a surge in heart-related conditions that require surgical intervention. Moreover, continuous technological progress—such as the development of advanced artificial heart valves, improved ablation devices, and compact ventricular assist systems—is enhancing surgical precision and outcomes. Increasing healthcare expenditures, especially in developed countries, along with supportive reimbursement policies, are encouraging wider adoption of cardiac surgical procedures. The growing preference for minimally invasive surgeries is also propelling demand for next-generation surgical devices that reduce patient recovery time and procedural risks.

Market Restraints:

Despite favorable market trends, certain challenges may hinder the growth of the cardiac surgery devices market. High costs associated with sophisticated surgical equipment and procedures remain a significant barrier, particularly in low-income and developing regions. The complexity of cardiac surgeries and the need for highly skilled healthcare professionals can also limit procedural accessibility. In addition, regulatory hurdles, lengthy device approval timelines, and potential complications associated with certain devices can affect market penetration and end-user trust. Furthermore, variability in reimbursement structures across different countries can lead to inconsistent adoption rates.

Market Opportunities:

The cardiac surgery devices market offers considerable opportunities, particularly through innovations in robotics, AI-driven surgical systems, and wearable cardiac monitoring devices. The expansion of healthcare infrastructure in emerging economies, coupled with growing awareness of heart health, is unlocking new avenues for market players. Investments in R&D and collaborations with hospitals and research institutions are paving the way for next-gen surgical solutions. There is significant potential in developing portable, less invasive devices tailored for outpatient procedures and cardiac catheterization labs. Additionally, government initiatives and public-private partnerships aimed at combating cardiovascular diseases are expected to boost demand for advanced surgical technologies in the coming years.

Key Questions Answered in the Report:

• What are the major factors driving the global cardiac surgery devices market forward?
• Which product segments and regions are exhibiting the highest growth potential?
• How are technological innovations shaping the future of cardiac surgery devices?
• Who are the leading companies in this market and what strategies are they pursuing?
• What are the emerging opportunities and long-term projections for this industry?

Competitive Intelligence and Business Strategy:

Top players in the cardiac surgery devices market—including Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, and Edwards Lifesciences Corporation—are focusing on innovation, portfolio expansion, and strategic collaborations. These companies are actively investing in the development of minimally invasive and robot-assisted surgical devices to enhance patient outcomes and surgical efficiency. Partnerships with healthcare providers and academic institutions help accelerate product validation and adoption. Key strategies also include entering untapped markets, optimizing manufacturing and supply chains, and leveraging digital health solutions to integrate real-time monitoring with surgical interventions.

Companies Covered in This Report:

• Abbott Laboratories
• Medtronic Plc.
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• B. Braun Melsungen AG
• Terumo Corporation
• LivaNova PLC
• Edwards Lifesciences Corporation
• Cardinal Health
• Stryker Corporation
• Cook Medical
• Philips Healthcare
• Getinge Group
• Hologic, Inc.

Market Segmentation

By Product:

• Cardiopulmonary Bypass Systems
• Cardiac Ablation Devices
• Artificial Heart Valves
• Ventricular Assist Devices (VADs)
• Implantable Rhythm Management Devices
• Surgical Instruments
• Others

By Indication:

• Coronary Procedures
• Valve Procedures
• Transplant & Replacement Procedures
• Arrhythmia-Related Procedures

By End-user:

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories
• Academic and Research Institutes

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Cardiac Surgery Devices Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Disease Epidemiology
3.4. Reimbursement Scenario
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Price Trend Analysis, 2025
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences
5. Global Cardiac Surgery Devices Market Outlook:
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.3. Global Cardiac Surgery Devices Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2024
5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
5.3.3.1. Cardiopulmonary Bypass Systems
5.3.3.2. Cardiac Ablation Devices
5.3.3.3. Artificial Heart Valves
5.3.3.4. Ventricular Assist Devices (VADs)
5.3.3.5. Implantable Rhythm Management Devices
5.3.3.6. Surgical Instruments
5.3.3.7. Others
5.3.4. Market Attractiveness Analysis: Product
5.4. Global Cardiac Surgery Devices Market Outlook: Procedure
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Bn) Analysis, By Procedure, 2019-2024
5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2025-2032
5.4.3.1. Coronary Procedures
5.4.3.2. Valve Procedures
5.4.3.3. Transplant & Replacement Procedures
5.4.3.4. Arrhythmia-Related Procedures
5.4.4. Market Attractiveness Analysis: Procedure
5.5. Global Cardiac Surgery Devices Market Outlook: End-user
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
5.5.3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
5.5.3.1. Hospitals
5.5.3.2. Cardiac Centers
5.5.3.3. Ambulatory Surgical Centers
5.5.3.4. Cardiac Catheterization Laboratories
5.5.3.5. Academic and Research Institutes
5.5.4. Market Attractiveness Analysis: End-user
6. Global Cardiac Surgery Devices Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Cardiac Surgery Devices Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product
7.2.3. By Procedure
7.2.4. By End-user
7.3. Market Size (US$ Bn) Analysis and Forecast By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
7.4.1. Cardiopulmonary Bypass Systems
7.4.2. Cardiac Ablation Devices
7.4.3. Artificial Heart Valves
7.4.4. Ventricular Assist Devices (VADs)
7.4.5. Implantable Rhythm Management Devices
7.4.6. Surgical Instruments
7.4.7. Others
7.5. Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2025-2032
7.5.1. Coronary Procedures
7.5.2. Valve Procedures
7.5.3. Transplant & Replacement Procedures
7.5.4. Arrhythmia-Related Procedures
7.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
7.6.1. Hospitals
7.6.2. Cardiac Centers
7.6.3. Ambulatory Surgical Centers
7.6.4. Cardiac Catheterization Laboratories
7.6.5. Academic and Research Institutes
7.7. Market Attractiveness Analysis
8. Europe Cardiac Surgery Devices Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product
8.2.3. By Procedure
8.2.4. By End-user
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
8.4.1. Cardiopulmonary Bypass Systems
8.4.2. Cardiac Ablation Devices
8.4.3. Artificial Heart Valves
8.4.4. Ventricular Assist Devices (VADs)
8.4.5. Implantable Rhythm Management Devices
8.4.6. Surgical Instruments
8.4.7. Others
8.5. Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2025-2032
8.5.1. Coronary Procedures
8.5.2. Valve Procedures
8.5.3. Transplant & Replacement Procedures
8.5.4. Arrhythmia-Related Procedures
8.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
8.6.1. Hospitals
8.6.2. Cardiac Centers
8.6.3. Ambulatory Surgical Centers
8.6.4. Cardiac Catheterization Laboratories
8.6.5. Academic and Research Institutes
8.7. Market Attractiveness Analysis
9. East Asia Cardiac Surgery Devices Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product
9.2.3. By Procedure
9.2.4. By End-user
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
9.4.1. Cardiopulmonary Bypass Systems
9.4.2. Cardiac Ablation Devices
9.4.3. Artificial Heart Valves
9.4.4. Ventricular Assist Devices (VADs)
9.4.5. Implantable Rhythm Management Devices
9.4.6. Surgical Instruments
9.4.7. Others
9.5. Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2025-2032
9.5.1. Coronary Procedures
9.5.2. Valve Procedures
9.5.3. Transplant & Replacement Procedures
9.5.4. Arrhythmia-Related Procedures
9.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
9.6.1. Hospitals
9.6.2. Cardiac Centers
9.6.3. Ambulatory Surgical Centers
9.6.4. Cardiac Catheterization Laboratories
9.6.5. Academic and Research Institutes
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Cardiac Surgery Devices Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product
10.2.3. By Procedure
10.2.4. By End-user
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
10.4.1. Cardiopulmonary Bypass Systems
10.4.2. Cardiac Ablation Devices
10.4.3. Artificial Heart Valves
10.4.4. Ventricular Assist Devices (VADs)
10.4.5. Implantable Rhythm Management Devices
10.4.6. Surgical Instruments
10.4.7. Others
10.5. Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2025-2032
10.5.1. Coronary Procedures
10.5.2. Valve Procedures
10.5.3. Transplant & Replacement Procedures
10.5.4. Arrhythmia-Related Procedures
10.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
10.6.1. Hospitals
10.6.2. Cardiac Centers
10.6.3. Ambulatory Surgical Centers
10.6.4. Cardiac Catheterization Laboratories
10.6.5. Academic and Research Institutes
10.7. Market Attractiveness Analysis
11. Latin America Cardiac Surgery Devices Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product
11.2.3. By Procedure
11.2.4. By End-user
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
11.4.1. Cardiopulmonary Bypass Systems
11.4.2. Cardiac Ablation Devices
11.4.3. Artificial Heart Valves
11.4.4. Ventricular Assist Devices (VADs)
11.4.5. Implantable Rhythm Management Devices
11.4.6. Surgical Instruments
11.4.7. Others
11.5. Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2025-2032
11.5.1. Coronary Procedures
11.5.2. Valve Procedures
11.5.3. Transplant & Replacement Procedures
11.5.4. Arrhythmia-Related Procedures
11.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
11.6.1. Hospitals
11.6.2. Cardiac Centers
11.6.3. Ambulatory Surgical Centers
11.6.4. Cardiac Catheterization Laboratories
11.6.5. Academic and Research Institutes
11.7. Market Attractiveness Analysis
12. Middle East & Africa Cardiac Surgery Devices Market Outlook:
12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Product
12.2.3. By Procedure
12.2.4. By End-user
12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
12.4.1. Cardiopulmonary Bypass Systems
12.4.2. Cardiac Ablation Devices
12.4.3. Artificial Heart Valves
12.4.4. Ventricular Assist Devices (VADs)
12.4.5. Implantable Rhythm Management Devices
12.4.6. Surgical Instruments
12.4.7. Others
12.5. Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2025-2032
12.5.1. Coronary Procedures
12.5.2. Valve Procedures
12.5.3. Transplant & Replacement Procedures
12.5.4. Arrhythmia-Related Procedures
12.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
12.6.1. Hospitals
12.6.2. Cardiac Centers
12.6.3. Ambulatory Surgical Centers
12.6.4. Cardiac Catheterization Laboratories
12.6.5. Academic and Research Institutes
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Abbott Laboratories
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Medtronic Plc.
13.3.3. Boston Scientific Corporation
13.3.4. Johnson & Johnson (Ethicon)
13.3.5. B. Braun Melsungen AG
13.3.6. Terumo Corporation
13.3.7. LivaNova PLC
13.3.8. Edwards Lifesciences Corporation
13.3.9. Cardinal Health
13.3.10. Stryker Corporation
13.3.11. Cook Medical
13.3.12. Philips Healthcare
13.3.13. Getinge Group
13.3.14. Hologic, Inc.
13.3.15. AtriCure, Inc.
13.3.16. Lepu Medical Technology Co. Ltd.
13.3.17. C.R. Bard (now part of BD)
13.3.18. Zoll Medical Corporation
13.3.19. Merit Medical Systems, Inc.
13.3.20. Asahi Intecc Co., Ltd.
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations